Clinical Trials Browser

Gastrointestinal Neoplasms × patritumab deruxtecan × 1 year × Clear all

NCT06596694 2026-06-01

Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)

Phase 1/2 Recruiting

Gastrointestinal

Gastrointestinal Neoplasms